Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...
LPUs grant owners a share in the partnership's income, avoiding double taxation. MLPs distribute available cash to unit holders after deducting maintenance capital. Limited partners only risk losing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback